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Background: To ensure the highest degree of accuracy for
the CIBMTR (Center for International Blood and Marrow
Transplant Research) data, the Penn State Milton S. Hershey
Medical Center Bone Marrow Transplant Program has
created Powerforms integrated into the EMR (Electronic
Medical Record) for GVHD (Graft versus Host Disease) and PS
(Performance Status) Assessment. In 2008, the data manager
was able to change the GVHD and PS Assessment from a
paper based method to an Electronic method.
Methods: The Bone Marrow Transplant Data Manager col-
lects GVHDAssessment for all Allogeneic Transplant patients,
and Assessments for patients on the research track at the
time periods of Day 100, six months, and yearly post-trans-
plant. The assessments are collected in the EMR. The
Attending Physicians then review, modify if needed, and sign
the assessment forms. These forms are used as source
documentation during CIBMTR Data Submission Audits.
Results: Our results show a decrease in errors found during a
CIBMT audit. The NMDP Audit in 2004 showed an overall
error rate (OER) of 1.2% and a Critical Error Rate (CER) of 2.8%.
PS errors were 47.9% of the CER, and GVHD errors were 14.6%
of the CER. In 2008, the audit showed a 1.7% OER and a 3.8%
CER. PS errors were 24.5% of the CER, and GVHDwere 3.8% of
the CER. In 2012, the audit showed a 0.7% OER and a 0.8% CER.
PS errors were 4.3% of CER and GVHD were 4.3% of CER.
Conclusion: Implementing the collection of GVHD and PS
assessment using the EMR has decreased the error rate found
on the CIBMTR Audit. The continuation of this method of
data collection can further reduce the error rate.
110
Accurate Data Entering a Difﬁcult Task
Camilla Roepstorff 1, Heidi Petersen 1, Hanne Larsen 2. 1 BMT
unit 4042, Rigshospitalet, Copenhagen, Denmark; 2 Bonkolab
5704, Rigshospitalet, Copenhagen, Denmark
Accurate patient data reporting is essential for the validity of
the scientiﬁc conclusions based on the international data-
bases (DB) of CIBMTR and EBMT. A study request from EMBT
listing patients with CML, raised suspicion that the list was
incomplete and that data had not been correctly reported. To
identify if data were missing and if so whether the problem
was, a) internal (local DB, data entering etc.), b) external
(EBMT/CIBMTR DB), c) random, or d) systematic, a quality
control survey was initiated.
Aim: To ensure all CML patients were reported correctly and
to identify the cause of possible errors.
Methods: Before the 1st of July 2013 the previous 20 patients
with CML treated with allogeneic stem cell transplantation
(SCT) were audited for data accuracy (Nov 5th 2007 - July
1st2013). The following data were checked for accuracy:
diagnosis, date of diagnoses, molecular markers, cytogenetic,
pre transplant treatment, and use of thyrosine kinase in-
hibitors (TKI). The data accuracy was checked in the EBMT,
the CIBMTR and the local DB. Data entering have been per-
formed by the EBMT, the CIBMTR and online by the data
managers at our institution.
Results: For the 20 CML patients, the diagnoses, the date of
diagnosis and cytogenetics were reported correctly in all
DBs. In relation to all other data, no error was identiﬁed in
the CIBMTR DB. However, two of 20 patients had a coding
error in relation to molecular markers in the EBMT DB, but
not in the local DB. In relation to treatment, two patients had
a coding error in the EBMT DB and one patient in the localDB. In relation to the ﬁrst course of TKI treatment three pa-
tients had a coding error in the EBMT DB and one in the local
DB. In relation to the second course of TKI eight patients had
a coding error in the local DB and two in the EBMT DB.
Conclusion: All data were entered correctly in the CIBMTR
DB, however errors were identiﬁed in the EBMTand the local
DB. Accordingly, the cause of errors is not related to lack of
knowledge of CML biology. The identiﬁed errors were not
systematically since they did not related to all patients.
Therefore it can be assumed that the errors were random
data entering errors. When analyzing the data entering
process in the three different data bases, the CIBMTR form
and DB are identical. However, the MED A form is not iden-
tically to the EBMT DB and neither of the forms is identical to
the local DB. Therefore interpretation of data during the data
entering process may be a source for coding errors. In the
future regular audit of data are recommended.111
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Background: Efﬁciency of delivery and coordination of pa-
tient care continues to be a challenge for most transplant
programs. Growth in transplant volumes at centers continues
to outpace growth in medical provider workforce. TIPS is a
transplant patient workﬂow management database centered
on streamlining workﬂow practices within a Blood and
Marrow Transplant (BMT) Program. The database associates
medical providers with speciﬁc roles that govern the various
stages of patient care. As each role completes speciﬁc trans-
plant tasks, TIPS transitions the patient to the subsequent
stage of the transplant. These stages include intake, pre-
transplant, admit/prep-regimen, post-transplant, discharge/
follow-up. TIPS Dashboard provides BMT Program adminis-
trators with real-time graphical representation of their
transplant patient population categorized by stage, disease,
staff workload etc. TIPS Reporting interface provides ease of
RFI reporting and data extraction. TIPS functionality includes
single click automated admission/discharge letters, insurance
authorizations request letters, transplant schedule report, and
comorbidity calculation. We have transitioned our in-house
Transplant Information Patient System (TIPS) to a web-based
collaborative platform to expand accessibility.
Methods: TIPS was originally developed on a Microsoft Ac-
cess database platform. However accessibility was limited
due to client side software availability, and local area
network access. These limitations were eliminated on tran-
sitioning to a web-based platform. The new TIPS web-based
version is developed on the Yii framework utilizing PHP,
JQuery, and CSS, with a MySQL backend database. TIPS
Table 1
Patient characteristics, shown as median (range) unless speciﬁed otherwise.
CB: cordblood
Number of HCTs (n) 196
Number of patients (n) 183
Age (years) 6.55 (0.1-22.7)
Weight (kg) 21 (3.66-96)
BSA (m2) 0.84 (0.14-2.1)
Starting day ATG (days before transplantation) 5.1 (1-19)




Bone marrow failure 8
Metabolic disease 13
Benign hematology 8
Stem cell source (%)
Bone marrow 42
Peripheral blood stem cells 11
CB 43
CB plus haplo or 2nd CB 4
Transplant number (1st,2nd,3rd) (n) 183, 12, 1
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Zend framework. TIPS database meets the HIPAA Security
Rule requirements, Title 45 CFR Part 160 and subparts A and
C of Part 164.
Results: TIPS web-based workﬂow tool allows all medical
providers involved in a patient’s transplant broader accessi-
bility to the electronic transplant data during the transplant
process. Medical providers can efﬁciently enter and retrieve
information in real-time. Center administrators are able to
obtain an overview of their Program’s performance, by
generating real-time reports, dashboard views of patient
volumes and distributions, which contribute towards pro-
grammatic quality improvement.
Discussion: TIPS has enabled us to efﬁciently manage pa-
tients throughout the transplant process and improve the
delivery of care and data reporting. Future TIPS enhance-
ments include direct importation of patient demographic
data from Enterprise Electronic Medical Record (EMR), and
connectivity to FormsNet, via AGNIS, for direct transfer of
center transplant data to CIBMTR.PHARMACY
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